Hemas Holdings Ltd. · CSELK:HHL.N0000
Hemas — Q1 FY25/26 Earnings Presentation
28 slides from Hemas's earnings presentation, 2025
Slide 1: Hemas Holdings PLC Investor Presentation Q1 FY25/26
Hemas Holdings PLC Investor Presentation- Q1 FY25/26
Slide 2: Who We Are
Who We Are Established in 1948, with a purpose of empowering families to live a better tomorrow, Hemas Holdings is one of Sri Lanka’s leading conglomerates listed in the Colombo Stock Exchange with focused interest in Consumer Brands and Healthcare. USD 1948 2003 2007 2013 2018 2022 76 241Mn Years i
Slide 3: Implications of Key Macro Economic Parameters on Hemas
Implications of Key Macro Economic Parameters on Hemas Interest Rates Stable Exchange Rates Global Commodity prices “Continued decline in AWPLR was “The Rupee remained relatively “Prices of key commodities witnessed during the year easing stable, positively impacting RM decreased Y-o-Y, positively t
Slide 4: Corporate Governance
Corporate Governance BOM Group CEO Nomination & Governance BOM (Board of Management) Consists of the senior leadership team of 11 members - Heads of our 6 businesses and 5 leaders from Corporate Committee Office. BOM is responsible for formulation and implementation of Group strategic plan and ensur
Slide 5: Long Range Plan: Key Focus Areas
Long Range Plan : Key Focus Areas ❖ Invest in complementary Hair and ❖ Shift focus to growing the ❖ Continue to strengthen a lean Beauty care, focus on local Morison brand in cardiac, diabetes, business model. consumer needs, and drive and complementary medication, household penetration in while enh
Slide 6: Awards and Recognitions
Awards and Recognitions Hemas Holdings PLC won the Silver award for Best Investor Relations Practices at the prestigious 2025 Annual Capital Market Awards organised by the CFA Society Sri Lanka. This recognition underscores the Group’s commitment to transparency, accountability, and excellence in st
Slide 7: New Product Launches During the Quarter
New Product Launches During the Quarter HCB - SL Gold Moisturising Hair Wax - Aloe Gold Nourishing Hair Wax - Almond
Slide 8: Financial Snapshot
Financial Snapshot EBIT by Sector Rs. Mn 6,000 3M contribution to the Group 5,000 2% 4,000 30% 68% 3,000 35% 81% 14% Revenue 2,000 1,000 EBIT 2% 0 Q1 FY 24/25 Q2 FY 24/25 Q3 FY 24/25 Q4 FY 24/25 Q1 FY 25/26 Consumer Healthcare Mobility -1,000 Consumer Brands Healthcare Mobility Other 3M Performance
Slide 9: Sector Performance Summary – Q1 FY 2025-26
Sector Performance Summary – Q1 FY 2025-26 Revenue Walk (LKR Mn) EBIT Walk (LKR Mn) 29,000 2,700 3,261 19 (2) 28,526 28,500 (229) 2,500 28,000 27,500 378 9 2,300 27,000 (97) 26,500 2,100 2,064 26,000 (157) 1,930 25,500 25,476 1,900 25,000 1,700 24,500 24,000 1,500
Slide 10: Continuing Operation EPS – Q1 FY 2025-26
Continuing Operation EPS – Q1 FY 2025-26 EPS Walk (LKR Per Share) 0.50 0.50 0.45 0.45 0.02 0.03 0.01 0.40 0.07 0.40 0.40 0.03 0.40 (0.00) (0.04) 0.04 0.35 0.35 0.32 0.32 0.30 0.30 0.25 0.25 0.20 0.20 0.15 0.15 0.10 0.10 0.05 0.05 - - EBIT Income Tax Q1 FY 26 Q1 FY 25 Net Fin Cost NCI
Slide 11: Capital Employed – Q1 FY 2025-26
Capital Employed – Q1 FY 2025-26 Sector Efficiency Capital Employed, ROCE, and EBIT by Key Sectors Consumer 50% Mobility LKR 719.1 Mn LKR 298.2 Mn Healthcare 40% LKR 1665.1 Mn 38.3% 36.0% 30% Group ROCE : 24.8 % 20% ROCE (%) 23.0% 10% 0% - 5,000.00 10,000.00 15,000.00 20,000.00 25,000.00 30,000.00 3
Slide 12: Consumer Brands
Consumer Brands ❖ Home and Personal Care - Sri Lanka ❖ Home and Personal Care - International ❖ Learning Segment
Slide 13: Consumer Brands
Consumer Brands Contribution to Group Sector Performance – 3M FY 2025-26 30% Revenue % Revenue (LKR Mn) Key Highlights 3M FY26 35% -2.6% (YoY) 3M FY25 • Revenue witnessed a moderate decline primarily due to price adjustments taken previously that were 16,055 driven by input cost deflation. EBITDA %
Slide 14: Home and Personal Care – Sri Lanka
Home and Personal Care – Sri Lanka 8 Key categories with market Purpose-driven brands touching the lives of the Sri Lankan consumer leading positions Extensions to the Portfolio Inclusive Strong roots Parenting Stronger Make a Celebrating Enabling Both parents together Positive Difference & Nurturin
Slide 15: Home and Personal Care – International
Home and Personal Care – International Locally led and localised in Bangladesh Reach in Bangladesh 2 Geographies Bangladesh & West Bengal • All products are exclusively designed for Bangladesh. Rural penetration by • Extensive product portfolio with multiple value 19.3% Hemas Key categories 3• Value
Slide 16: Home and Personal Care – Sri Lanka and International
Home and Personal Care – Sri Lanka and International Sri Lanka International Revenue Revenue Revenue (LKR Mn) • The personal care segment experienced volume-led growth -2.4% • Revenues increased driven by a better sales mix (YoY) • 'Kumarika', the flagship Value-Added Hair Oil • The Home care segmen
Slide 17: Learning Segment
Learning Segment Revenue 7 Key categories • Revenues were marginally lower with sales Revenue (LKR Mn) supported by increased sales and marketing efforts. High Efficiency and productivity through lean initiatives Profitability • Marginal drop in revenue, coupled with Market leader in key product Inc
Slide 18: Healthcare Sector
Healthcare Sector ❖ Pharmaceutical Import, Marketing and Distribution ❖ Pharmaceutical Manufacturing ❖ Hospitals
Slide 19: Healthcare
Healthcare Contribution to Group Sector Performance – 3M FY 2025-26 Revenue % 68% Revenue (LKR Mn) Key Highlights 20.2 % 3M FY26 (YoY) 3M FY25 63% 19,746 19,391 17,442 16,657 16,130 EBITDA % • Strong growth in Revenue driven 76% by expansion of services and Q1FY25 Q2FY25 Q3FY25 Q4FY25 Q1FY26 facilit
Slide 20: Pharmaceutical Import, Marketing, Distribution and Manufacturing
Pharmaceutical Import, Marketing, Distribution and Pharmaceutical Manufacturing Revenue Revenue (LKR Mn) • The Distribution business continues to hold its market-leading position. • Morison transitioned its distributed pharmaceutical agency 15.7 % operations to HPPL with the objective of unlocking g
Slide 21: Hospitals
Hospitals Revenue • Both outpatient and inpatient revenue recorded Revenue (LKR Mn) a steady increase. 200+ Beds • Revenue from the labs network also recorded a significant increase. 27.7 % (YoY) +50% Hospital occupancy Profitability • GP & EBITDA margins improved owing to the increased revenue and
Slide 22: Mobility Sector
Mobility Sector ❖Maritime ❖Aviation
Slide 23: Mobility
Mobility Contribution to Group Sector Performance – 3M FY 2025-26 2% Revenue % Revenue (LKR Mn) Key Highlights 4.0 % 3M FY26 2% (YoY) 3M FY25 • The Maritime sector witnessed an increase in volumes in the import 519 and export operations compared 487 495 to the previous year while freight 476 477 EBI
Slide 24: Environmental Agenda 2030 – Progress Snapshot
ENVIRONMENTAL AGENDA 2030 – PROGRESS SNAPSHOT 2030 GOAL FY 26 MILESTONE Facilitate the collection of 100% Collect back 50% of plastic of plastic sent to the sent to the market market/consumers through initiatives across the country 25% of Energy obtained through 9% of energy obtained renewable sourc
Slide 25: Social Impact: Focus Areas
SOCIAL IMPACT: FOCUS AREAS FY 26 Q1: 25,700+ FAMILIES EMPOWERED Creating Equal Supporting Health and Empowering Vulnerable Opportunities for Learning Well-being Communities 19,000+ 4,700+ 2,000+ Children and Teachers Families Families • Empowering women • Creating quality • Providing expert with ent
Slide 26: Sustainability Performance Improvements
SUSTAINABILITY PERFORMANCE IMPROVEMENTS FY 24 vs FY 25 Values of Fines for Non-Compliance Carbon Footprint 0.09MT with Laws and Regulations in the NONE (per Rs. Mn Revenue) - % Social Economic Area Total Work-Related Water Consumption (per Rs. Mn Revenue) - % 1.6 m3 Injury Rate 0.4 (per 100 employee
Slide 27: Key Priorities
Key Priorities Focus on Personal care, Beauty and wellness with a drive for premiumisation and exploring underpenetrated Markets Corporate Priorities Strengthening value prepositions to grow market share Accelerating the M&A opportunities Accelerate exports and international expansion Consumer Drivi
Slide 28: Disclaimer
Disclaimer The material in this presentation has been prepared by Hemas Holdings PLC (“Hemas”) and is general background information about Hemas’ activities current as at the date of this presentation. This information is given in summary form and does not purport to be complete. Information in this